| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hydrocephalus | 2 | 2023 | 43 | 1.690 |
Why?
|
| Hydrocephalus, Normal Pressure | 2 | 2023 | 14 | 1.010 |
Why?
|
| Adenylate Kinase | 1 | 2023 | 15 | 0.880 |
Why?
|
| Neuroblastoma | 10 | 2003 | 85 | 0.770 |
Why?
|
| Glioblastoma | 4 | 2019 | 156 | 0.740 |
Why?
|
| Glioma | 5 | 2017 | 102 | 0.710 |
Why?
|
| Nuclear Proteins | 4 | 2014 | 760 | 0.660 |
Why?
|
| Brain Neoplasms | 6 | 2017 | 306 | 0.620 |
Why?
|
| MicroRNAs | 4 | 2019 | 620 | 0.580 |
Why?
|
| Meningioma | 3 | 2012 | 58 | 0.540 |
Why?
|
| Neoplastic Stem Cells | 2 | 2015 | 203 | 0.510 |
Why?
|
| Chromosomes, Human, Pair 1 | 5 | 2003 | 24 | 0.490 |
Why?
|
| Gene Deletion | 5 | 2012 | 297 | 0.480 |
Why?
|
| Genes, Neurofibromatosis 2 | 2 | 2012 | 6 | 0.480 |
Why?
|
| Ribosome Subunits, Small, Eukaryotic | 1 | 2014 | 3 | 0.480 |
Why?
|
| RNA, Ribosomal, 18S | 1 | 2014 | 6 | 0.480 |
Why?
|
| Meningeal Neoplasms | 2 | 2012 | 57 | 0.460 |
Why?
|
| Protein Biosynthesis | 2 | 2014 | 296 | 0.440 |
Why?
|
| Alternative Splicing | 3 | 2012 | 120 | 0.420 |
Why?
|
| Chromosomal Instability | 1 | 2012 | 20 | 0.390 |
Why?
|
| Proteins | 3 | 2023 | 743 | 0.380 |
Why?
|
| Cell Proliferation | 2 | 2019 | 943 | 0.370 |
Why?
|
| Mice | 14 | 2023 | 10331 | 0.340 |
Why?
|
| Cell Movement | 3 | 2011 | 426 | 0.340 |
Why?
|
| Animals | 20 | 2023 | 19752 | 0.330 |
Why?
|
| Cell Line, Tumor | 11 | 2019 | 1383 | 0.330 |
Why?
|
| Gene Expression Regulation, Neoplastic | 6 | 2019 | 483 | 0.330 |
Why?
|
| Nerve Tissue Proteins | 4 | 2012 | 417 | 0.320 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 11 | 2012 | 524 | 0.310 |
Why?
|
| Zebrafish | 5 | 2010 | 323 | 0.310 |
Why?
|
| Neoplasm Invasiveness | 4 | 2019 | 248 | 0.290 |
Why?
|
| Mutation | 5 | 2023 | 2466 | 0.290 |
Why?
|
| Neoplasms | 3 | 2014 | 1261 | 0.280 |
Why?
|
| Humans | 34 | 2023 | 60093 | 0.250 |
Why?
|
| Tumor Cells, Cultured | 10 | 2012 | 454 | 0.240 |
Why?
|
| Neuroectodermal Tumors | 1 | 2004 | 2 | 0.240 |
Why?
|
| Genes, Tumor Suppressor | 4 | 2003 | 73 | 0.240 |
Why?
|
| Oncogene Proteins | 1 | 2004 | 42 | 0.230 |
Why?
|
| Choroid Plexus | 1 | 2023 | 16 | 0.220 |
Why?
|
| Ependyma | 1 | 2023 | 9 | 0.220 |
Why?
|
| Forkhead Transcription Factors | 1 | 2023 | 118 | 0.210 |
Why?
|
| Transcription Factors | 1 | 2010 | 1459 | 0.200 |
Why?
|
| Cilia | 1 | 2023 | 157 | 0.190 |
Why?
|
| RNA, Messenger | 7 | 2010 | 1469 | 0.190 |
Why?
|
| Pancreatic Neoplasms | 1 | 2004 | 327 | 0.190 |
Why?
|
| ErbB Receptors | 2 | 2012 | 113 | 0.180 |
Why?
|
| Mice, Nude | 5 | 2012 | 260 | 0.170 |
Why?
|
| Acid Anhydride Hydrolases | 1 | 1999 | 5 | 0.160 |
Why?
|
| Liquid Biopsy | 1 | 2019 | 4 | 0.160 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2019 | 11 | 0.160 |
Why?
|
| Tissue Array Analysis | 1 | 2019 | 31 | 0.160 |
Why?
|
| Nanotubes, Carbon | 1 | 2019 | 19 | 0.160 |
Why?
|
| Leukemia | 1 | 1999 | 54 | 0.160 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 1999 | 99 | 0.160 |
Why?
|
| Gene Expression Regulation | 2 | 2023 | 1538 | 0.160 |
Why?
|
| Phenotype | 2 | 2015 | 1157 | 0.160 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2010 | 81 | 0.160 |
Why?
|
| Cell Adhesion | 1 | 2019 | 209 | 0.160 |
Why?
|
| Melatonin | 1 | 2018 | 66 | 0.150 |
Why?
|
| Membrane Proteins | 3 | 2012 | 845 | 0.150 |
Why?
|
| Serotonin | 1 | 2018 | 63 | 0.150 |
Why?
|
| Mitogen-Activated Protein Kinase 7 | 1 | 2017 | 10 | 0.150 |
Why?
|
| Neuroprotective Agents | 1 | 2018 | 72 | 0.150 |
Why?
|
| Hexokinase | 1 | 2017 | 11 | 0.150 |
Why?
|
| Cell Differentiation | 1 | 2023 | 1297 | 0.150 |
Why?
|
| Down-Regulation | 2 | 2017 | 305 | 0.150 |
Why?
|
| Caspases | 4 | 2006 | 165 | 0.140 |
Why?
|
| DNA-Binding Proteins | 2 | 2001 | 1136 | 0.140 |
Why?
|
| Osteoporosis | 1 | 2018 | 139 | 0.140 |
Why?
|
| Disease Progression | 5 | 2012 | 1054 | 0.140 |
Why?
|
| Liver Diseases | 1 | 2018 | 136 | 0.140 |
Why?
|
| Blotting, Western | 4 | 2012 | 594 | 0.140 |
Why?
|
| Immunoglobulin G | 1 | 1999 | 449 | 0.140 |
Why?
|
| Brain Injuries | 1 | 2018 | 137 | 0.130 |
Why?
|
| Ventriculoperitoneal Shunt | 1 | 2016 | 30 | 0.130 |
Why?
|
| Brain | 2 | 2023 | 1493 | 0.130 |
Why?
|
| Sleep | 1 | 2018 | 223 | 0.130 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 | 2001 | 48 | 0.130 |
Why?
|
| Transcription, Genetic | 1 | 1999 | 847 | 0.120 |
Why?
|
| Dual-Specificity Phosphatases | 1 | 2014 | 7 | 0.110 |
Why?
|
| rho-Associated Kinases | 1 | 2014 | 11 | 0.110 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 2014 | 18 | 0.110 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor Proteins | 1 | 2014 | 16 | 0.110 |
Why?
|
| Protein Subunits | 1 | 2014 | 165 | 0.110 |
Why?
|
| Cell Nucleolus | 1 | 2014 | 68 | 0.110 |
Why?
|
| Loss of Heterozygosity | 3 | 2010 | 24 | 0.110 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2014 | 67 | 0.110 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2014 | 196 | 0.110 |
Why?
|
| Cytoplasm | 1 | 2014 | 274 | 0.110 |
Why?
|
| Alcoholism | 1 | 2016 | 308 | 0.110 |
Why?
|
| Homozygote | 3 | 2001 | 116 | 0.100 |
Why?
|
| Apoptosis | 3 | 2010 | 1040 | 0.100 |
Why?
|
| DNA, Neoplasm | 3 | 2001 | 51 | 0.100 |
Why?
|
| SKP Cullin F-Box Protein Ligases | 1 | 2012 | 9 | 0.100 |
Why?
|
| Tumor Suppressor Proteins | 3 | 2003 | 194 | 0.100 |
Why?
|
| Checkpoint Kinase 2 | 1 | 2012 | 24 | 0.100 |
Why?
|
| DNA Mutational Analysis | 2 | 2003 | 196 | 0.100 |
Why?
|
| Neoplasm Grading | 1 | 2012 | 75 | 0.100 |
Why?
|
| Sequence Tagged Sites | 2 | 2001 | 4 | 0.090 |
Why?
|
| Leukemia, Myeloid | 2 | 2002 | 31 | 0.090 |
Why?
|
| RNA Interference | 2 | 2014 | 592 | 0.090 |
Why?
|
| Snail Family Transcription Factors | 1 | 2010 | 25 | 0.090 |
Why?
|
| Breast Neoplasms | 1 | 2019 | 1132 | 0.090 |
Why?
|
| Tumor Burden | 1 | 2010 | 62 | 0.090 |
Why?
|
| Epidermal Growth Factor | 1 | 2010 | 48 | 0.090 |
Why?
|
| Adult | 3 | 2023 | 15980 | 0.090 |
Why?
|
| Middle Aged | 3 | 2023 | 16540 | 0.090 |
Why?
|
| Neoplasm Transplantation | 1 | 2010 | 160 | 0.090 |
Why?
|
| Gene Expression Profiling | 2 | 2010 | 712 | 0.090 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2010 | 48 | 0.080 |
Why?
|
| Receptors, TNF-Related Apoptosis-Inducing Ligand | 1 | 2009 | 7 | 0.080 |
Why?
|
| Genomic Imprinting | 1 | 2010 | 49 | 0.080 |
Why?
|
| Wnt Proteins | 1 | 2010 | 91 | 0.080 |
Why?
|
| Neovascularization, Pathologic | 1 | 2010 | 138 | 0.080 |
Why?
|
| Stromal Cells | 1 | 2009 | 65 | 0.080 |
Why?
|
| DNA Methylation | 4 | 2010 | 273 | 0.080 |
Why?
|
| Xenograft Model Antitumor Assays | 3 | 2019 | 183 | 0.080 |
Why?
|
| Neoplasm Staging | 1 | 2010 | 460 | 0.080 |
Why?
|
| Embryo, Nonmammalian | 2 | 2006 | 169 | 0.080 |
Why?
|
| Bone Marrow Cells | 1 | 2009 | 232 | 0.080 |
Why?
|
| Male | 9 | 2019 | 27963 | 0.080 |
Why?
|
| Transfection | 1 | 2010 | 676 | 0.080 |
Why?
|
| Zebrafish Proteins | 2 | 2006 | 150 | 0.070 |
Why?
|
| Animals, Genetically Modified | 2 | 2006 | 281 | 0.070 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 3 | 2003 | 16 | 0.070 |
Why?
|
| Immunohistochemistry | 4 | 2012 | 854 | 0.070 |
Why?
|
| PTEN Phosphohydrolase | 2 | 2019 | 83 | 0.070 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2010 | 630 | 0.070 |
Why?
|
| Fish Proteins | 1 | 2006 | 7 | 0.070 |
Why?
|
| Promoter Regions, Genetic | 2 | 2010 | 661 | 0.060 |
Why?
|
| Amino Acid Sequence | 4 | 2003 | 1580 | 0.060 |
Why?
|
| Molecular Sequence Data | 4 | 2003 | 1973 | 0.060 |
Why?
|
| Endopeptidases | 1 | 2006 | 68 | 0.060 |
Why?
|
| Chromosome Aberrations | 2 | 2003 | 64 | 0.060 |
Why?
|
| Cytosol | 1 | 2006 | 170 | 0.060 |
Why?
|
| Carcinoma, Islet Cell | 1 | 2004 | 1 | 0.060 |
Why?
|
| N-Myc Proto-Oncogene Protein | 1 | 2004 | 22 | 0.060 |
Why?
|
| Sarcoma, Ewing | 2 | 2003 | 11 | 0.060 |
Why?
|
| RNA, Neoplasm | 2 | 2001 | 34 | 0.060 |
Why?
|
| Rhabdomyosarcoma | 2 | 2003 | 17 | 0.060 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2003 | 357 | 0.060 |
Why?
|
| Mutation, Missense | 2 | 2003 | 180 | 0.060 |
Why?
|
| Tumor Protein p73 | 2 | 2001 | 4 | 0.060 |
Why?
|
| Transgenes | 1 | 2004 | 176 | 0.060 |
Why?
|
| Tumor Suppressor Protein p14ARF | 1 | 2003 | 12 | 0.060 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2006 | 299 | 0.050 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2003 | 53 | 0.050 |
Why?
|
| Islets of Langerhans | 1 | 2004 | 267 | 0.050 |
Why?
|
| Gene Expression | 2 | 2010 | 807 | 0.050 |
Why?
|
| Time Factors | 1 | 2010 | 3619 | 0.050 |
Why?
|
| Neurons | 2 | 2006 | 863 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2002 | 7 | 0.050 |
Why?
|
| Genetic Linkage | 1 | 2002 | 101 | 0.050 |
Why?
|
| Chromosome Banding | 1 | 2001 | 10 | 0.050 |
Why?
|
| Allelic Imbalance | 1 | 2001 | 6 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2001 | 10 | 0.050 |
Why?
|
| Genome, Human | 1 | 2003 | 219 | 0.050 |
Why?
|
| Charcot-Marie-Tooth Disease | 1 | 2001 | 7 | 0.050 |
Why?
|
| Cell Line | 2 | 2012 | 2018 | 0.050 |
Why?
|
| Chromosome Deletion | 1 | 2001 | 41 | 0.050 |
Why?
|
| Molecular Motor Proteins | 1 | 2001 | 34 | 0.050 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2001 | 38 | 0.050 |
Why?
|
| DNA Fragmentation | 1 | 2001 | 35 | 0.050 |
Why?
|
| Cell Cycle Proteins | 1 | 2003 | 387 | 0.050 |
Why?
|
| Cloning, Molecular | 1 | 2001 | 381 | 0.040 |
Why?
|
| Caspase 3 | 1 | 2001 | 104 | 0.040 |
Why?
|
| Insulin | 1 | 2004 | 688 | 0.040 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2001 | 148 | 0.040 |
Why?
|
| Microtubules | 1 | 2001 | 210 | 0.040 |
Why?
|
| Enzyme Activation | 2 | 2014 | 356 | 0.040 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2000 | 155 | 0.040 |
Why?
|
| Oligonucleotides, Antisense | 3 | 2006 | 133 | 0.040 |
Why?
|
| Point Mutation | 1 | 2000 | 164 | 0.040 |
Why?
|
| DNA Primers | 1 | 2000 | 292 | 0.040 |
Why?
|
| Cells, Cultured | 3 | 2011 | 2101 | 0.040 |
Why?
|
| Microscopy, Electron, Transmission | 2 | 2011 | 135 | 0.040 |
Why?
|
| Female | 6 | 2019 | 31229 | 0.040 |
Why?
|
| Polymorphism, Genetic | 1 | 2000 | 194 | 0.040 |
Why?
|
| Hemocyanins | 1 | 1999 | 23 | 0.040 |
Why?
|
| Oncogene Protein v-akt | 1 | 2019 | 15 | 0.040 |
Why?
|
| Carcinoma, Small Cell | 1 | 1999 | 21 | 0.040 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 1999 | 51 | 0.040 |
Why?
|
| Receptor, Melatonin, MT2 | 1 | 2018 | 3 | 0.040 |
Why?
|
| Receptor, Melatonin, MT1 | 1 | 2018 | 5 | 0.040 |
Why?
|
| Antibody Specificity | 1 | 1999 | 100 | 0.040 |
Why?
|
| Receptors, Melatonin | 1 | 2018 | 34 | 0.040 |
Why?
|
| Immunoblotting | 1 | 1999 | 190 | 0.040 |
Why?
|
| Base Sequence | 1 | 2001 | 1307 | 0.040 |
Why?
|
| DNA Copy Number Variations | 1 | 2019 | 67 | 0.040 |
Why?
|
| Reference Values | 1 | 1999 | 322 | 0.040 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 1999 | 68 | 0.040 |
Why?
|
| Neoplasm Metastasis | 1 | 2019 | 196 | 0.040 |
Why?
|
| Single-Cell Analysis | 1 | 2019 | 93 | 0.040 |
Why?
|
| Rabbits | 1 | 1999 | 329 | 0.040 |
Why?
|
| Bone Marrow | 1 | 1999 | 178 | 0.040 |
Why?
|
| Surface Properties | 1 | 2019 | 274 | 0.040 |
Why?
|
| Regeneration | 1 | 2018 | 92 | 0.040 |
Why?
|
| Neoplasm Proteins | 1 | 1999 | 277 | 0.040 |
Why?
|
| Proto-Oncogene Proteins | 1 | 1999 | 316 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 1999 | 697 | 0.030 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 1999 | 170 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2018 | 282 | 0.030 |
Why?
|
| Epithelial Cells | 1 | 2019 | 376 | 0.030 |
Why?
|
| Prognosis | 3 | 2010 | 1591 | 0.030 |
Why?
|
| Presenilin-2 | 2 | 2006 | 20 | 0.030 |
Why?
|
| Proto-Oncogenes | 1 | 1996 | 8 | 0.030 |
Why?
|
| Genes, myc | 1 | 1996 | 19 | 0.030 |
Why?
|
| Gene Amplification | 1 | 1996 | 25 | 0.030 |
Why?
|
| Aged | 3 | 2017 | 13581 | 0.030 |
Why?
|
| Gene Silencing | 1 | 2017 | 379 | 0.030 |
Why?
|
| Blotting, Northern | 2 | 2006 | 148 | 0.030 |
Why?
|
| E2F Transcription Factors | 1 | 2014 | 16 | 0.030 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2014 | 16 | 0.030 |
Why?
|
| Calmodulin-Binding Proteins | 1 | 2014 | 22 | 0.030 |
Why?
|
| Actomyosin | 1 | 2014 | 21 | 0.030 |
Why?
|
| Retinoblastoma Protein | 1 | 2014 | 37 | 0.030 |
Why?
|
| CDC2 Protein Kinase | 1 | 2014 | 33 | 0.030 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2014 | 42 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 1999 | 577 | 0.030 |
Why?
|
| AC133 Antigen | 1 | 2012 | 5 | 0.030 |
Why?
|
| Immunoprecipitation | 1 | 2012 | 116 | 0.020 |
Why?
|
| Expressed Sequence Tags | 2 | 2002 | 27 | 0.020 |
Why?
|
| Child, Preschool | 3 | 2003 | 1850 | 0.020 |
Why?
|
| Disease Models, Animal | 2 | 2011 | 2078 | 0.020 |
Why?
|
| Dextrans | 1 | 2011 | 44 | 0.020 |
Why?
|
| Magnetite Nanoparticles | 1 | 2011 | 28 | 0.020 |
Why?
|
| Infant | 3 | 2003 | 1532 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2014 | 860 | 0.020 |
Why?
|
| Luciferases | 1 | 2011 | 109 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 2012 | 472 | 0.020 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2011 | 37 | 0.020 |
Why?
|
| Caspase 9 | 2 | 2001 | 22 | 0.020 |
Why?
|
| Iron | 1 | 2011 | 139 | 0.020 |
Why?
|
| Glycoproteins | 1 | 2012 | 194 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2012 | 344 | 0.020 |
Why?
|
| Chromosome Mapping | 2 | 2002 | 293 | 0.020 |
Why?
|
| Caspase 8 | 2 | 2001 | 61 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2012 | 636 | 0.020 |
Why?
|
| Gene Dosage | 1 | 2010 | 60 | 0.020 |
Why?
|
| Principal Component Analysis | 1 | 2010 | 60 | 0.020 |
Why?
|
| RNA | 2 | 2003 | 405 | 0.020 |
Why?
|
| beta Catenin | 1 | 2010 | 85 | 0.020 |
Why?
|
| Protein Binding | 1 | 2014 | 1555 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2010 | 252 | 0.020 |
Why?
|
| Cell- and Tissue-Based Therapy | 1 | 2009 | 38 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2010 | 291 | 0.020 |
Why?
|
| DNA | 2 | 2003 | 793 | 0.020 |
Why?
|
| Peptides | 1 | 2012 | 550 | 0.020 |
Why?
|
| Cell Division | 1 | 2010 | 442 | 0.020 |
Why?
|
| Genotype | 1 | 2010 | 643 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2009 | 448 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2014 | 855 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2010 | 454 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2009 | 400 | 0.020 |
Why?
|
| Cell Survival | 1 | 2009 | 558 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2007 | 219 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2006 | 43 | 0.020 |
Why?
|
| Aspartic Acid Endopeptidases | 1 | 2006 | 29 | 0.020 |
Why?
|
| Biopsy | 1 | 2007 | 376 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2016 | 5264 | 0.020 |
Why?
|
| Cell Count | 1 | 2006 | 129 | 0.020 |
Why?
|
| Transcription Factor RelA | 1 | 2006 | 49 | 0.020 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2006 | 67 | 0.020 |
Why?
|
| In Situ Hybridization | 1 | 2006 | 215 | 0.020 |
Why?
|
| Body Patterning | 1 | 2006 | 85 | 0.020 |
Why?
|
| Indoles | 1 | 2006 | 102 | 0.020 |
Why?
|
| Receptors, Notch | 1 | 2006 | 100 | 0.020 |
Why?
|
| Child | 3 | 2000 | 4332 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2016 | 6136 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2006 | 805 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p15 | 1 | 2003 | 9 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 2003 | 52 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2003 | 286 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2003 | 195 | 0.010 |
Why?
|
| Physical Chromosome Mapping | 1 | 2002 | 4 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2011 | 2052 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2003 | 665 | 0.010 |
Why?
|
| Caspase 10 | 1 | 2001 | 1 | 0.010 |
Why?
|
| Mice, Neurologic Mutants | 1 | 2001 | 14 | 0.010 |
Why?
|
| Genes, Neoplasm | 1 | 2001 | 24 | 0.010 |
Why?
|
| Microscopy, Immunoelectron | 1 | 2001 | 31 | 0.010 |
Why?
|
| Mice, Inbred ICR | 1 | 2001 | 27 | 0.010 |
Why?
|
| Synaptic Vesicles | 1 | 2001 | 26 | 0.010 |
Why?
|
| Axonal Transport | 1 | 2001 | 31 | 0.010 |
Why?
|
| Mutagenesis, Insertional | 1 | 2001 | 88 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2002 | 253 | 0.010 |
Why?
|
| Immunophenotyping | 1 | 2001 | 185 | 0.010 |
Why?
|
| Exons | 1 | 2001 | 193 | 0.010 |
Why?
|
| CpG Islands | 1 | 2001 | 212 | 0.010 |
Why?
|
| Evolution, Molecular | 1 | 2002 | 295 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2010 | 2892 | 0.010 |
Why?
|
| Alzheimer Disease | 1 | 2006 | 560 | 0.010 |
Why?
|
| Hippocampus | 1 | 2001 | 243 | 0.010 |
Why?
|
| Gene Duplication | 1 | 1999 | 32 | 0.010 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 1 | 1999 | 26 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2003 | 678 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2001 | 744 | 0.010 |
Why?
|
| Acute Disease | 1 | 1999 | 661 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2001 | 1998 | 0.010 |
Why?
|
| Genetic Markers | 1 | 1996 | 122 | 0.010 |
Why?
|
| Biomarkers, Tumor | 1 | 1996 | 465 | 0.010 |
Why?
|
| Adolescent | 1 | 1999 | 5957 | 0.000 |
Why?
|